92 related articles for article (PubMed ID: 2131166)
1. Inflammatory bowel diseases and thymus disorder: reactivity of thymocytes with monoclonal antibodies.
Mizuno Y; Muraoka M; Shimabukuro K; Toda K; Miyagawa K; Yoshimatsu H; Tsuchiya M
Bull Tokyo Dent Coll; 1990 May; 31(2):137-41. PubMed ID: 2131166
[TBL] [Abstract][Full Text] [Related]
2. E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies.
Makiyama K; Selby WS; Jewell DP
Clin Exp Immunol; 1983 May; 52(2):350-4. PubMed ID: 6602677
[TBL] [Abstract][Full Text] [Related]
3. Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies.
Aiso S; Yoshida T; Watanabe M; Hibi T; Asakura H; Tsuchiya M; Tsuru S
J Clin Lab Immunol; 1984 Mar; 13(3):137-9. PubMed ID: 6609240
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
5. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
6. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
Dopp AC; Mutchnick MG; Goldstein AL
Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
[TBL] [Abstract][Full Text] [Related]
7. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
8. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
[TBL] [Abstract][Full Text] [Related]
9. The circulating common gamma chain (CD132) in inflammatory bowel disease.
Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
[TBL] [Abstract][Full Text] [Related]
10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
12. An increased number of CD40-high monocytes in patients with Crohn's disease.
Sawada-Hase N; Kiyohara T; Miyagawa J; Ueyama H; Nishibayashi H; Murayama Y; Kashihara T; Nakahara M; Miyazaki Y; Kanayama S; Nezu R; Shinomura Y; Matsuzawa Y
Am J Gastroenterol; 2000 Jun; 95(6):1516-23. PubMed ID: 10894589
[TBL] [Abstract][Full Text] [Related]
13. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis.
Andoh A; Fujiyama Y; Yoshioka U; Sasaki M; Araki Y; Tsujikawa T; Bamba T
Int J Mol Med; 2002 May; 9(5):499-502. PubMed ID: 11956656
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells.
Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869
[TBL] [Abstract][Full Text] [Related]
16. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
18. Assessment of in vivo activated T cells in patients with Crohn's disease.
Raedler A; Schreiber S; de Weerth A; Voss A; Peters S; Greten H
Hepatogastroenterology; 1990 Feb; 37(1):67-71. PubMed ID: 2312042
[TBL] [Abstract][Full Text] [Related]
19. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.
Fujii N; Itoyama Y; Goto I
Ann Neurol; 1990 Jun; 27(6):642-6. PubMed ID: 2113791
[TBL] [Abstract][Full Text] [Related]
20. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
Danis VA; Heatley RV
Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]